The Trump administration promised to drastically cut prescription drugs prices in the US, where the industry makes most of its money.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
There’s been this little obstacle standing in the way of a functioning nationwide marijuana market: the law.
The weight loss drug market could be worth $100 billion in the next few years. Naturally, other companies want in.
The EU’s antitrust investigation claims that China is artificially flooding the market with cheap EVs via enormous state subsidies.
De Beers, the world’s largest diamond producer, said it plans to shutter its lab-grown jewelry brand LightBox.
While many agree US railroads desperately need refurbishing, some question why federal dollars should support a highly privatized industry.
McDonald’s has had a tenuous relationship with its franchise operators as of late. A new round of royalty fee hikes isn’t likely to help.
If Hollywood studios want to settle the current dual strike, they may have to get much more open about just how popular their shows are.
The UK and US announced a “historic” trade deal Thursday that does little to reduce Washington’s overall global trade war.
A G7 plan to crack down on sanctioned Russian diamonds has run into resistance from some of the industry’s biggest players.
Federal Reserve chair Jerome Powell has met his match in the ongoing fight against inflation: skyrocketing oil costs.
Netflix is rolling out the first major redesign of its home hub since 2013, hoping people might watch more if inundated with less.
Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.